Markers of disease severity in chronic obstructive pulmonary disease
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Pulmonary Pharmacology & Therapeutics
- Vol. 19 (3), 189-199
- https://doi.org/10.1016/j.pupt.2005.05.001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Clinical biomarkers in drug discovery and developmentNature Reviews Drug Discovery, 2003
- COPD: problems in diagnosis and measurementEuropean Respiratory Journal, 2003
- Airway inflammation in COPD: physiological outcome measures and induced sputumEuropean Respiratory Journal, 2003
- Long-term Repeatability of Induced Sputum Cells and Inflammatory Markers in Stable, Moderately Severe COPDChest, 2003
- Association of Tumor Necrosis Factor-α Gene Promoter Polymorphism With Low Attenuation Areas on High-Resolution CT in Patients With COPDChest, 2002
- Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax, 2000
- Fixed- and random-effects models in meta-analysis.Psychological Methods, 1998
- Predicted values: how should we use them?Thorax, 1988
- The natural history of chronic airflow obstruction.BMJ, 1977
- Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility.Thorax, 1966